홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
  1. 홈
  2. /화합물

Cyclandelate

HCID 178903369
노트반응
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
54110-27-9
표준 SMILES
CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1
InChIKey
WZHCOOQXZCIUNC-UHFFFAOYSA-N
분자식
C17H24O3
평균 분자량
276.4 g/mol

개요

Cyclandelate is the ester obtained by formal condensation of mandelic acid and 3,3,5-tricyclohexanol. It is a direct-acting smooth muscle relaxant used to dilate blood vessels. It has a role as a vasodilator agent. It is a carboxylic ester and a secondary alcohol. It is functionally related to a mandelic acid and a 3,3,5-trimethylcyclohexanol.

이름 및 식별자

우선 이름
Cyclandelate
IUPAC
(3,3,5-trimethylcyclohexyl) 2-hydroxy-2-phenylacetate
영어명
Bs 572
분자식
C17H24O3
분자량
276.37066

이름 및 동의어

cyclandelate456-59-7CyclomandolCyclolytCyclospasmolPerebralSpasmioneCapilanSepyronCiclandelatoCiclospasmolClandilon
이름 더 보기
CyclergineCyclobralSaiclateSancyclanSpasmocyclonArto-espasmol3,3,5-Trimethylcyclohexyl mandelateNovodil

데이터베이스 식별자

CAS
54110-27-9
ChEMBL
CHEMBL1480987
ChEBI
CHEBI:3988
UNII
4139O1OAY2
EC Number
207-271-6
Nikkaji
J2.048F

물성

구조 계산 물성

XLogP
4.2
극성 표면적
46.5 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
3
회전 가능 결합 수
4
무거운 원자 수
20
형식 전하
0
복잡도
331

실험 및 물리화학적 성질

Color/FormCRYSTALS
Solubility · 3건

PRACTICALLY INSOL IN WATER; SOL IN LIPOIDS & THEIR SOLVENTS

FREELY SOL IN PETROLEUM ETHER, ETHANOL; SOL IN DIETHYL ETHER, ACETONE

9.97e-02 g/L

Boiling Point192-194 °C @ 14 MM HG
Melting Point · 3건

50-53

50-53 °C

56 °C

Physical DescriptionSolid
Collision Cross Section · 2건

186.2 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

156.39 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H319 (97.5%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

P264+P265, P280, P305+P351+P338, and P337+P317 (click each P-code to see the statement)

Aggregated GHS information provided per 40 reports by companies from 2 notifications to the ECHA C&L Inventory.

유해성 정보

Hazard Classes and CategoriesEye Irrit. 2 (97.5%)

독성 정보

Human Toxicity Excerpts · 3건

CYCLANDELATE APPEARS TO PRODUCE LITTLE SERIOUS TOXICITY. HOWEVER, ORAL DOSES OF 200 MG OR MORE ARE ASSOC WITH SIGNIFICANT INCIDENCE OF UNPLEASANT SIDE EFFECTS, INCL GASTROINTESTINAL UPSETS, FLUSHING, TINGLING, HEADACHE, DIZZINESS, & SWEATING.

SIDE EFFECTS INCLUDE...NAUSEA...& HYPOTENSION.

...IT HAS BEEN CLAIMED THAT CYCLANDELATE REDUCED OPHTHALMIC BLOOD PRESSURE BUT INCR FLOW IN RETINAL ARTERIES. IT APPEARS THAT CYCLANDELATE PRESENTS NO SIGNIFICANT THREAT OF RAISING OCULAR PRESSURE IN OPEN-ANGLE GLAUCOMA NOR ANY THREAT OF PRECIPITATING ANGLE-CLOSURE GLAUCOMA...

화학 및 산업

약리 정보

ATC Code · 2건

C - Cardiovascular system

QC - Cardiovascular system

PharmacodynamicsCyclandelate is in a class of drugs called vasodilators. Cyclandelate relaxes veins and arteries, which makes them wider and allows blood to pass through them more easily.
Mechanism of Action · 3건

Cyclandelate produces peripheral vasodilation by a direct effect on vascular smooth muscle. Pharmacological action may be due to calcium-channel antagonism.

...MOST OF ITS PHARMACOLOGICAL PROPERTIES ARE VERY SIMILAR TO THOSE OF PAPAVERINE & OF MANY SYNTHETIC ANTISPASMODICS PROMOTED PRIMARILY FOR EFFECTS ON SMOOTH MUSCLE.

PAPAVERINE IS POTENT INHIBITOR OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE FOUND IN MANY TISSUES & CAN INCR CONCN OF CYCLIC ADENOSINE 3',5'-MONOPHOSPHATE (CYCLIC AMP). SINCE CYCLIC AMP HAS BEEN IMPLICATED AS POSSIBLE MEDIATOR OF BETA-ADRENERGIC RELAXATION OF SMOOTH MUSCLE, SUCH MECHANISM OF ACTION...IS PLAUSIBLE. /PAPAVERINE/

Biological Half-Life(3-)-H-LABELED CYCLANDELATE WAS DETECTED & QUANTITATED. EFFECTIVE HALF-LIFE VALUES IN VARIOUS RAT TISSUES WERE 2.8-4.1 DAYS.
MeSH Pharmacological ClassificationDrugs used to cause dilation of the blood vessels.
Absorption, Distribution and Excretion · 2건

Well absorbed following oral administration.

MAX UPTAKE @ 1 HR FOR MOST RAT TISSUES WHILE BRAIN, DIAPHRAGM, STOMACH, & VEIN SHOWED MAX LEVELS @ 24 HR. LEVELS NEGLIGIBLE IN 28 DAYS.

Cellular LocationsMembrane

용도 및 제조

UsesMEDICATION

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
Methods of Manufacturing · 1건

PREPD BY ESTERIFICATION OF MANDELIC ACID WITH 3, 3,5-TRIMETHYLCYCLOHEXANOL USING SULFURIC ACID AS CATALYST: BROCK ET AL, ARZNEIMITTEL-FORSCH 2, 165 (1952); FUNCKE ET AL, IBID 3, 503 (1953)...BRITISH PATENT 707.227 (1954 TO BROCADES-STHEEMAN). PURIFICATION: FLITTER, US PATENT 3,663,597 (1972 TO AMERICAN HOME PRODUCTS).

Formulations/PreparationsDRUG IS AVAILABLE IN 100-MG TABLETS & 200-MG CAPSULES.
General Manufacturing InformationBenzeneacetic acid, .alpha.-hydroxy-, 3,3,5-trimethylcyclohexyl ester: ACTIVE